Fibroblast Activation Protein Alpha-Targeted Nanoparticles for Tumor Microenvironment Remodeling and Antitumor Therapy in Triple-Negative Breast Cancer
Fuente:
Zenodo
Saved in:
| Main Authors: | Lameirinhas, A, Díez, P, Hicke, FJ, Ágreda-Roca, A, Torres-Ruiz, S, Sánchez-Serrano, P, Tapia, M, Lluch, A, Bermejo, B, Cejalvo, JM, Martínez-Máñez, R, Eroles, P, Garrido-Cano, I |
|---|---|
| Format: | Recurso digital |
| Language: | English |
| Published: |
Zenodo
2026
|
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Nanoparticle‐Mediated Tumor Microenvironment Remodeling Favors the Communication with the Immune Cells for Tumor Killing
by: Elena Lucena‐Sánchez, et al.
Published: (2024)
by: Elena Lucena‐Sánchez, et al.
Published: (2024)
Baicalin‐Loaded Bifunctional Albumin Nanoparticles Inhibit Triple‐Negative Breast Cancer Growth by Remodeling the Inflammatory Microenvironment
by: Fengjie Liu, et al.
Published: (2025)
by: Fengjie Liu, et al.
Published: (2025)
A Self‐Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple‐Negative Breast Cancer Therapy
by: Jia‐Yi Lin, et al.
Published: (2025)
by: Jia‐Yi Lin, et al.
Published: (2025)
ITGB1 Regulates Triple‐Negative Breast Cancer Development by Modulating the Tumor Microenvironment
by: Nuozi Song, et al.
Published: (2026)
by: Nuozi Song, et al.
Published: (2026)
Impacto económico de los tratamientos compasivos sobre el gasto farmacéutico en un hospital
by: A. L. Fernández Eroles
Published: (2006)
by: A. L. Fernández Eroles
Published: (2006)
Dual Role of LBH589 in Triple‐Negative Breast Cancer: Inhibition of Tumor Growth and Enhancement of Antitumor Immunity
by: Liang Anjing, et al.
Published: (2026)
by: Liang Anjing, et al.
Published: (2026)
Tumoural Hypoxic Extracellular Vesicles Foster a Protective Microenvironment in Triple‐Negative Breast Cancer
by: Bianca Cruz Pachane, et al.
Published: (2025)
by: Bianca Cruz Pachane, et al.
Published: (2025)
Novel ATR/PARP1 Dual Inhibitors Demonstrate Synergistic Antitumor Efficacy in Triple‐Negative Breast Cancer Models
by: Yuan Gao, et al.
Published: (2025)
by: Yuan Gao, et al.
Published: (2025)
Trihydroxylated Anthocyanins Potentiate Effects of Docetaxel in Mesenchymal Triple Negative Breast Cancer Cells
by: Mafalda Ribeiro, et al.
Published: (2025)
by: Mafalda Ribeiro, et al.
Published: (2025)
Spatial Transcriptomics of TMJ Reveals a Remodeling Fibroblast‐Immune Microenvironment Driving Arthritis Pain
by: Ziying Lin, et al.
Published: (2026)
by: Ziying Lin, et al.
Published: (2026)
Identifying Therapeutic Targets for Triple-Negative Breast Cancer using a Novel Mathematical Model of the Tumor Microenvironment
by: Adams, Kyle, et al.
Published: (2026)
by: Adams, Kyle, et al.
Published: (2026)
PGAM1 Orchestrates Cell Cycle Progression, Glycolytic Reprogramming, and Immunosuppressive Microenvironment in Triple‐Negative Breast Cancer
by: Shunshun Zhang, et al.
Published: (2026)
by: Shunshun Zhang, et al.
Published: (2026)
Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer
by: Dongdong Zheng, et al.
Published: (2025)
by: Dongdong Zheng, et al.
Published: (2025)
A Dual‐Function Mitochondria‐Targeted Polyoxometalate Nanomicelle Boosts Pyroptosis‐Dependent Antitumor Immune Response in Triple‐Negative Breast Cancer
by: Qingqing Dou, et al.
Published: (2026)
by: Qingqing Dou, et al.
Published: (2026)
Brain Metastasis in Triple‐Negative Breast Cancer
by: Eduarda Bustamante, et al.
Published: (2024)
by: Eduarda Bustamante, et al.
Published: (2024)
Dual‐Targeted Biomimetic Hybrid Nanovesicles for Tumor Microenvironment Reprogramming and Intratumoral Bacteria Eradication in Triple‐Negative Breast Cancer
by: Maolin Li, et al.
Published: (2025)
by: Maolin Li, et al.
Published: (2025)
Targeting IL27RA Enhances Immunotherapy in Triple‐Negative Breast Cancer by Modulating Tumor Cells and the Tumor Microenvironment
by: Jiachi Xu, et al.
Published: (2026)
by: Jiachi Xu, et al.
Published: (2026)
Cancer‐Derived Extracellular Vesicle ITGB2 Promotes the Progression of Triple‐Negative Breast Cancer via the Activation of Cancer‐Associated Fibroblasts
by: Jingjing Fan, et al.
Published: (2025)
by: Jingjing Fan, et al.
Published: (2025)
mRNA‐Lipid Nanoparticle‐Mediated Restoration of PTPN14 Exhibits Antitumor Effects by Overcoming Anoikis Resistance in Triple‐Negative Breast Cancer
by: Wei Li, et al.
Published: (2024)
by: Wei Li, et al.
Published: (2024)
Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer
by: Yuhan Liu, et al.
Published: (2024)
by: Yuhan Liu, et al.
Published: (2024)
A Dual Bispecific Hydrolysis Peptide‐Drug Conjugate Responsive to Micro‐Acidic and Reduction Circumstance Promotes Antitumor Efficacy in Triple‐Negative Breast Cancer
by: Tingting Tang, et al.
Published: (2024)
by: Tingting Tang, et al.
Published: (2024)
Hydrogen Therapy Reverses Cancer‐Associated Fibroblasts Phenotypes and Remodels Stromal Microenvironment to Stimulate Systematic Anti‐Tumor Immunity
by: Xiaoyan Meng, et al.
Published: (2024)
by: Xiaoyan Meng, et al.
Published: (2024)
Mitochondria‐Targeted Ferroptosis Nanodrug for Triple‐Negative Breast Cancer Therapy via Fatty Acid Metabolism Remodeling and Tumor Bacterial Symbiosis Inhibition
by: Yunyi Shan, et al.
Published: (2025)
by: Yunyi Shan, et al.
Published: (2025)
Targeting IGF1R Overcomes Armored and Cold Tumor Microenvironment and Boosts Immune Checkpoint Blockade in Triple‐Negative Breast Cancer
by: Mengyun Wan, et al.
Published: (2025)
by: Mengyun Wan, et al.
Published: (2025)
Metal‐(Acyclic Diaminocarbene) Complexes Demonstrate Nanomolar Antiproliferative Activity against Triple‐Negative Breast Cancer
by: Svetlana A. Katkova, et al.
Published: (2024)
by: Svetlana A. Katkova, et al.
Published: (2024)
Metal‐(Acyclic Diaminocarbene) Complexes Demonstrate Nanomolar Antiproliferative Activity against Triple‐Negative Breast Cancer
by: Svetlana A. Katkova, et al.
Published: (2024)
by: Svetlana A. Katkova, et al.
Published: (2024)
Survival Analysis of Young Triple-Negative Breast Cancer Patients
by: O, M. Mehdi Owrang, et al.
Published: (2024)
by: O, M. Mehdi Owrang, et al.
Published: (2024)
Therapeutic Potential of Copper Complexes in Triple Negative Breast Cancer
by: Kumudini Paliwal, et al.
Published: (2025)
by: Kumudini Paliwal, et al.
Published: (2025)
Selective Antiproliferative and Apoptotic Effects of 2,6‐Diketopiperazines on MDA‐MB‐231 Triple‐Negative Breast Cancer
by: Flor Paulina Garrido González, et al.
Published: (2025)
by: Flor Paulina Garrido González, et al.
Published: (2025)
Targeted Nanoprobes Enabled Precision Theranostics in Triple‐Negative Breast Cancer
by: Ke Ma, et al.
Published: (2025)
by: Ke Ma, et al.
Published: (2025)
Genistein in Triple‐Negative Breast Cancer: Anticancer Mechanisms and Structural Modifications
by: Yaling Peng, et al.
Published: (2025)
by: Yaling Peng, et al.
Published: (2025)
Synergistic Combinations for Improved Therapeutic Outcomes in Triple Negative Breast Cancer
by: Avani Jha, et al.
Published: (2026)
by: Avani Jha, et al.
Published: (2026)
A Supramolecular, Triple Negative Breast Cancer‐Targeting Avidin‐Photosensitizer
by: Bingjie Gao, et al.
Published: (2025)
by: Bingjie Gao, et al.
Published: (2025)
Targeting Triple‐Negative Breast Cancer: Resistance Mechanisms and Therapeutic Advancements
by: Rachana Raman, et al.
Published: (2025)
by: Rachana Raman, et al.
Published: (2025)
Ultrasound Radiomics Features to Identify Patients With Triple‐Negative Breast Cancer
by: Zhe Hu, et al.
Published: (2024)
by: Zhe Hu, et al.
Published: (2024)
España es, sin duda alguna, un socio excelente de China en sus vínculos comerciales con América Latina" / Iv n M ñez
by: Máñez, Iván
Published: (2009)
by: Máñez, Iván
Published: (2009)
¿Influye la Retroalimentación Correctiva en el Uso de la Retroalimentación Elaborada en un Entorno Digital?
by: Ignacio Máñez
Published: (2020)
by: Ignacio Máñez
Published: (2020)
Systematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR
by: Yiran Fang, et al.
Published: (2025)
by: Yiran Fang, et al.
Published: (2025)
Extracellular Vesicle Proteome Analysis Improves Diagnosis of Recurrence in Triple‐Negative Breast Cancer
by: Ju‐Yong Hyon, et al.
Published: (2025)
by: Ju‐Yong Hyon, et al.
Published: (2025)
Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Systematic Review of Breast and Node Pathologic Response
by: Milena Martello Cristófalo, et al.
Published: (2026)
by: Milena Martello Cristófalo, et al.
Published: (2026)
Similar Items
-
Nanoparticle‐Mediated Tumor Microenvironment Remodeling Favors the Communication with the Immune Cells for Tumor Killing
by: Elena Lucena‐Sánchez, et al.
Published: (2024) -
Baicalin‐Loaded Bifunctional Albumin Nanoparticles Inhibit Triple‐Negative Breast Cancer Growth by Remodeling the Inflammatory Microenvironment
by: Fengjie Liu, et al.
Published: (2025) -
A Self‐Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple‐Negative Breast Cancer Therapy
by: Jia‐Yi Lin, et al.
Published: (2025) -
ITGB1 Regulates Triple‐Negative Breast Cancer Development by Modulating the Tumor Microenvironment
by: Nuozi Song, et al.
Published: (2026) -
Impacto económico de los tratamientos compasivos sobre el gasto farmacéutico en un hospital
by: A. L. Fernández Eroles
Published: (2006)